# PK/PD and Clinial Outcomes of Beta-lactams in ICU Patients

> **NCT03858387** · — · UNKNOWN · sponsor: **Prince of Songkla University** · enrollment: 102 (estimated)

## Conditions studied

- Critical Illness
- Bacterial Infections

## Interventions

- **DRUG:** Meropenem
- **DRUG:** Imipenem

## Key facts

- **NCT ID:** NCT03858387
- **Lead sponsor:** Prince of Songkla University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2020-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03858387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03858387, "PK/PD and Clinial Outcomes of Beta-lactams in ICU Patients". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03858387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*